pI: 7.0546 |
Length (AA): 896 |
MW (Da): 101324 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
264 | 336 | 3zux (A) | 31 | 105 | 33.00 | 0 | 0.02 | 0.0255 | 3.53 |
264 | 336 | 3zux (A) | 31 | 105 | 33.00 | 0.41 | 0.02 | 0.0913 | 3.54 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_132227)
Species | Accession | Gene Product |
---|---|---|
Caenorhabditis elegans | CELE_Y73B6BL.31 | Protein Y73B6BL.31, isoform A |
Drosophila melanogaster | Dmel_CG42322 | CG42322 gene product from transcript CG42322-RN |
Echinococcus granulosus | EgrG_000134600 | solute carrier family 35 member F3 |
Echinococcus granulosus | EgrG_000134400 | solute carrier family 35 member F3 |
Echinococcus multilocularis | EmuJ_000134600 | solute carrier family 35 member F3 |
Echinococcus multilocularis | EmuJ_000134400 | solute carrier family 35 member F3 |
Homo sapiens | ENSG00000151812 | solute carrier family 35, member F4 |
Homo sapiens | ENSG00000183780 | solute carrier family 35, member F3 |
Loa Loa (eye worm) | LOAG_07791 | hypothetical protein |
Mus musculus | ENSMUSG00000021852 | solute carrier family 35, member F4 |
Mus musculus | ENSMUSG00000057060 | solute carrier family 35, member F3 |
Onchocerca volvulus | OVOC2112 |
|
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 25.8% | 318 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 23.7% | 177 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 23.0% | 257 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 21.5% | 307 aa | Compounds | References |